Jump to content
RemedySpot.com

RFC Study p53 Transmittal B

Rate this topic

Guest guest

By Guest guest
in Health, Medicine and Natural Healing 08

 Share

Recommended Posts

Guest guest

Guest guest

Posted
Posted

In Abstract No. 781, in concluding, they express " However, 17p- and

unmutated VH status remain predictors for shorter PFS and OS

independently of the overall improvement by FCR. " They also provide an

odds and hazards ratio matrix. I personally would like to see all the

numbers with respective characteristics & go thru the calcs.

If someone has the complete data set of this Roche sponsored clinical

trial for marketing their MabThera (rituximab) in Europe, I think I

would enjoy reading it.

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
 Share
Go to topic listing
×
×
  • Create New...